Delivery Order SPE2DB25D3201-SPE2DB25FNWDB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,532.22 to AmerisourceBergen Drug Corp for Neomycin-Polymyxin-Gramicidin eye drops (10mL) on July 24, 2025, with an ultimate completion date of July 25, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement to support military and federal healthcare systems'...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,626.20 by the Defense Logistics Agency's Medical Supply Chain on August 15, 2025, with an ultimate completion date of August 18, 2025. The contract, awarded without set-aside restrictions through competitive procedures, concerns the supply of NEVANAC 0.1% eye drops in a 3 milliliter quantity. This delivery order is structured as a firm fixed price...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $30,256.76 for MIEBO 100% eye drop supply (3ml units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. The...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,735.11 on August 11, 2025, for the supply of Neomycin-Polymyxin-HC Ear Suspension (10mL) under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The contract, which is not set-aside, has an ultimate completion date of August 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,261.74 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Neomycin-Polymyxin-Dexamethasone eye drops (5 mL) with a ceiling value of $1,210.91 under a firm fixed-price contract. This delivery order, issued on August 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Miebo 100% eye drops (3 mL), with a ceiling value of $18,826.55. The contract utilizes a firm fixed-price delivery order structure with no set-aside designation, indicating competitive award based on AmerisourceBergen's demonstrated capability to meet federal procurement requirements. The place of performance is located in Conshohocken,...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for XDEMVY 0.25% drop in 10ml format, valued at $1,223.59 with a firm fixed price structure. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026. The delivery order is non-competitive...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,032.18 by the Defense Logistics Agency's Medical Supply Chain on July 25, 2025, for the supply of Neomycin-Polymyxin-HC ear solution in 10 milliliter quantities. The award is structured as a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $30,438.63 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3mL units) on August 26, 2025, with completion scheduled for August 27, 2025. This firm fixed-price contract was competitively awarded without set-aside provisions to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNWDBDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,356.62 delivery order on September 3, 2025, for the supply of Neomycin-Poly-HC eye drops in 7.5ml quantities. This firm fixed price, non-set-aside contract is expected to be completed by September 4, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical supplier that serves military and veteran healthcare systems through competitively awarded contracts with the Defense Logistics Agency. The company's substantial IDC enables it to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This specific delivery order for ophthalmic medication reflects the company's role in fulfilling routine medical supply needs for defense healthcare customers, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/3/25 |